Susquehanna International Group
BNTCW

Susquehanna International Group’s Benitec Biopharma Limited BNTCW Stock Holding History

Susquehanna International Group’s Portfolio BNTCW Stock Details BNTCW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-50,000
Closed -$20K – 10611
2017
Q4 		$20K Hold
50,000
– – ﹤0.01% 9067
2017
Q3 		$15K Hold
50,000
– – ﹤0.01% 8671
2017
Q2 		$18K Hold
50,000
– – ﹤0.01% 9038
2017
Q1 		$15K Hold
50,000
– – ﹤0.01% 8761
2016
Q4 		$5K Buy
+50,000
New +$5.04K ﹤0.01% 9488

Other funds holding BNTCW

CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Susquehanna International Group's BNTCW Position: Q1 2018 in Review

Susquehanna International Group sold out of Benitec Biopharma Limited (BNTCW) in Q1 2018, closing a stake of 50,000 shares — an estimated $20K sold.

Susquehanna International Group first reported a position in BNTCW in Q4 2016 and held it in 5 quarters. The position peaked at $20K in Q4 2017. 1 fund tracked by Wall St. Rank holds BNTCW as of Q1 2018.

  • Susquehanna International Group reported no remaining Benitec Biopharma Limited position as of Q1 2018 after selling out during the quarter.
  • Susquehanna International Group sold 50,000 Benitec Biopharma Limited shares in Q1 2018, an estimated $20K.
  • Susquehanna International Group first reported a position in Benitec Biopharma Limited in Q4 2016 and held it in 5 quarters.
  • Susquehanna International Group's Benitec Biopharma Limited position peaked at $20K in Q4 2017.
  • 1 fund tracked by Wall St. Rank held Benitec Biopharma Limited as of Q1 2018.

Based on Susquehanna International Group's 13F filing for Q1 2018, filed 15 May 2018.